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Abstract:
Bone cement based on poly(methyl methacrylate) (PMMA) powder and 
methyl methacrylate (MMA) liquid is a very popular biomaterial used for 
the fixation of artificial joints. However, there is a risk of this cement 
loosening from bone because of a lack of bone-bonding bioactivity. 
Apatite formation in the body environment is a prerequisite for cement 
bioactivity. Additionally, suppression of infection during implantation is 
required for bone cements to be successfully introduced into the human 
body. In this study, we modified PMMA cement with -
methacryloxypropyltrimetoxysilane and calcium acetate to introduce 
bioactive properties and 2-(tert-butylamino)ethyl methacrylate 
(TBAEMA) to provide antibacterial properties. The long-term antibacterial 
activity is attributed to the copolymerization of TBAEMA and MMA. As the 
TBAEMA content increased, the setting time increased and the 
compressive strength decreased. After soaking in simulated body fluid, 
an apatite layer was detected within 7 d, irrespective of the TBAEMA 
content. The cement showed better antibacterial activity against Gram-
negative E. Coli than Gram-positive bacteria; however, of the Gram-
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2 Bone cement based on poly(methyl methacrylate) (PMMA) powder and methyl methacrylate 
3 (MMA) liquid is a very popular biomaterial used for the fixation of artificial joints. However, there 
4 is a risk of this cement loosening from bone because of a lack of bone-bonding bioactivity. Apatite 
5 formation in the body environment is a prerequisite for cement bioactivity. Additionally, 
6 suppression of infection during implantation is required for bone cements to be successfully 
7 introduced into the human body. In this study, we modified PMMA cement with -
8 methacryloxypropyltrimetoxysilane and calcium acetate to introduce bioactive properties and 2-
9 (tert-butylamino)ethyl methacrylate (TBAEMA) to provide antibacterial properties. The long-term 
10 antibacterial activity is attributed to the copolymerization of TBAEMA and MMA. As the 
11 TBAEMA content increased, the setting time increased and the compressive strength decreased. 
12 After soaking in simulated body fluid, an apatite layer was detected within 7 d, irrespective of the 
13 TBAEMA content. The cement showed better antibacterial activity against Gram-negative E. Coli 
14 than Gram-positive bacteria; however, of the Gram-positive bacteria investigated, B. subtilis was 
15 more susceptible than S. aureus.
16
17 Keywords: PMMA bone cement, 2-(tert-butylamino)ethyl methacrylate, mechanical property, 
18 apatite formation, antibacterial activity
19
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1 1.  Introduction
2 Bone cement comprising poly(methyl methacrylate) (PMMA) powder and methyl 
3 methacrylate (MMA) liquid is a popular bone-repair material used in orthopedic surgery for fixing 
4 artificial joints and curing osteoporosis-related fractures.1,2 The fixation strength of PMMA cement 
5 to bone depends primarily on mechanical interlocking.3 Several strategies have been employed to 
6 improve cement–bone interactions, for example PMMA bone cement is often mixed with bioactive 
7 ceramic powders such as sintered hydroxyapatite and glass-ceramic A-W.4,5 However, large 
8 amounts of the ceramic are required to make the cement bioactive as the added particles make 
9 limited contact with body fluid. 
10 Bioactive ceramics described above generally achieve the bone-bonding as follows. Bone-
11 like apatite layer is formed on the ceramics via chemical reaction with body fluid. Then, adsorption, 
12 proliferation and differentiation of osteoblast are occurred. Consequently, bone matrix is calcified 
13 to fill the gap between the bone tissue and the implants.6 Inspired by the bone-bonding mechanism 
14 of bioactive ceramics, we previously reported that PMMA cement exhibited apatite-forming 
15 properties in simulated body fluid (SBF) when it was modified with an alkoxysilane, such as -
16 methacryloxypropyltrimethoxysilane (MPS), and water-soluble calcium salts.7,8 MPS contributes 
17 to silanol (Si-OH) group formation and is able to induce heterogeneous apatite nucleation, which 
18 is accelerated by released Ca2+. This type of apatite formation in SBF is required for materials to 
19 show bioactivity.9 Novel nanomaterials such as graphene and boron nitride nanotube are attractive 
20 for improvement of biological compatibility of PMMA and calcium phosphate bone cements.10,11 
21 Another challenge facing PMMA bone cement is bacterial infection as a result of it being 
22 implanted in the human body.12 For this purpose, PMMA cements loaded with various antibiotics 
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1 such as gentamicin and vancomycin have been developed and some of them have been already 
2 commercialized13,14. In order to extend the antibacterial spectra to resistant bacteria, viruses and 
3 so on, non-antibiotic PMMA cements have been recently developed. For example, antibacterial 
4 PMMA cements loaded with silver and gold nanoparticles have been proposed.15,16 Graphene and 
5 iron ions are also known as novel antibacterial chemical species.17,18 In addition, control in release 
6 profiles of antibacterial agents introduces a challenge. It is reported that sustained release of 
7 antibiotics from the cements can be achieved by incorporation of carboxyl acid-functionalized 
8 block copolymers19 and mesoporous silica20, and by encapsulation of the antibiotics with various 
9 inorganic and organic compounds21. 
10 Quaternary ammonium has good antibacterial activity against a wide range of 
11 microorganisms, while exhibiting only low toxicity in mammals.22 Lenoir et al.23 assumed that the 
12 positively charged amino groups replace divalent cations of the outer membrane, which leads to 
13 membrane disruption. Copolymerization of MMA and a monomer containing antibacterial 
14 quaternary ammonium is expected to lead to long-term antibacterial activity. Abid et al. prepared 
15 antibacterial PMMA cement by copolymerization of a quaternary ammonium dendrimer.24 As a 
16 result, compressive strength of the cement was around 50 MPa and the prepared cement showed 
17 antibacterial activity against both Gram-positive and Gram-negative bacteria. The cement is 
18 expected to inhibit infection in prosthesis and surgery. However, neither evaluation of bioactivity 
19 nor improvement of the bioactivity was attempted.
20 In this study, PMMA cement was modified with 2-(tert-butylamino)ethyl methacrylate 
21 (TBAEMA, H2C=C(CH3)CO2CH2CH2NHC(CH3)3), MPS, and calcium acetate. The assumed 
22 chemical structure is schematically illustrated in Fig. 1. Its bioactivity was assessed in vitro using 
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1 SBF and its antibacterial activity was evaluated by culturing two Gram-positive bacteria and a 
2 Gram-negative bacterium. The obtained results are discussed in terms of TBAEMA content.
3
4 2.  Materials and Methods
5 2.1.  Materials
6 PMMA powder (MB-4C) was procured from Sekisui Plastics Co., Ltd. (Tokyo, Japan). 
7 Calcium acetate monohydrate, MMA, and N,N-dimethyl-p-toluidine (NDT) were obtained from 
8 FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan). TBAEMA was purchased from 
9 Sigma-Aldrich Co. LLC (Missouri, USA). Benzoyl peroxide (BPO), LB Lennox culture medium 
10 and the chemicals for the preparation of SBF were acquired from Nacalai Tesque Inc. (Kyoto, 
11 Japan). MPS was purchased from Shin-Etsu Chemical Co., Ltd. (Tokyo, Japan). Ca(CH3COO)2 
12 was dried at 220°C and BPO was recrystallized from ethanol. The other chemicals were of 
13 analytical grade and were used without further purification. Commercial gentamicin-loaded 
14 antibacterial cement (Cobalt G-HV, Zimmer Biomet, IN, USA) was used as a reference. This type 
15 of cement contains 2% of the gentamicin in powder component.
16
17 2.2.  Cement preparation
18 The PMMA based bone cement included two components: the powder source and the liquid 
19 source. The powder source was composed of PMMA, Ca(CH3COO)2, and BPO. The liquid source 
20 comprised MMA, MPS, TBAEMA, and NDT. The detailed composition of each component is 
21 shown in Table 1. The mixing ratio of powder/liquid was 1/0.5 (g/g). The temperature and relative 
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1 humidity during mixing were maintained at 23 ±2°C and 50±10%, respectively. The paste was 
2 injected into a cylindrical or rectangular polypropylene mold for setting. TBAEMA/(MMA+ 
3 TBAEMA) mass ratio of the cements was ranged from 0 to 40%, because addition of larger amount 
4 of TBAEMA made the setting of the cement quite difficult.
5
6 2.3.  Setting time and temperature measurement 
7 A mixed paste of 1.5 g of cement was used to determine the setting time. A weight of 300 g 
8 was loaded onto the mixed paste with a Vicat needle apparatus (A-004, JAPAN MECC Co., Ltd., 
9 Tokyo, Japan) with a cross section of 1 mm2. The setting time was defined as the time when the 
10 trace of the Vicat needle did not remain on the surface of the cement. The test was repeated five 
11 times for each cement. Temperature change of the mixed paste was monitored by a temperature 
12 data logger attached with a Pt resistance temperature detector (TR-81, T&D Corporation, Nagano, 
13 Japan). Five specimens were tested for each cement composition.
14
15 2.4.  Mechanical properties
16 Cylindrical samples 6 mm in diameter and 12 mm in height were used for the compressive 
17 strength measurements. All of the specimens were subjected to a compressive load with a cross-
18 head speed of 1 mm/min controlled by a universal testing machine (Autograph AG, Shimadzu Co., 
19 Kyoto, Japan) until fracture occurred. The compressive strength was calculated from the fracture 
20 load and the cross-sectional area of the samples. Five specimens were tested for each cement 
21 composition.
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2 2.5.  Bioactivity test in SBF
3 The bioactivity of the obtained PMMA bone cement was evaluated in vitro in terms of apatite 
4 formation on the surface in SBF (Na+ 142.0, K+ 5.0, Mg2+ 1.5, Ca2+ 2.5, Cl− 147.8, HCO3− 4.2, 
5 HPO42− 1.0, SO42− 0.5 mM). The SBF was prepared by successively dissolving NaCl, NaHCO3, 
6 KCl, K2HPO4·3H2O, MgCl2·6H2O, CaCl2, and Na2SO4 in ultrapure water. The pH of the SBF was 
7 adjusted to 7.40 using 1 M HCl and 50 mM tris(hydroxymethyl)aminomethane. Details of the SBF 
8 preparation were reported previously.25 The cements were shaped into rectangular pieces with 
9 dimensions of 10 × 10 × 1 mm3 and then immersed in polystyrene bottles containing 35 mL of 
10 SBF at 36.5°C. After soaking for a certain period of time, the cements were taken out, rinsed with 
11 pure water three times, and dried in an oven at 65°C for 24 h. 
12
13 2.6.  Characterization 
14 The surfaces of the cements were characterized by thin-film X-ray diffractometery (TF-XRD, 
15 MXP3V, MAC Science Ltd., Yokohama, Japan), Fourier-transform infrared spectroscopy (FT-IR, 
16 FT/IR-6100, JASCO Co., Tokyo, Japan) and scanning electron microscopy (S-3500N, Hitachi Co., 
17 Tokyo, Japan). In the TF-XRD experiments, the incident beam was fixed at 1° to the surface of 
18 each substrate and the scan rate was 0.02°·s−1. In FT-IR measurements, an attenuated total 
19 reflection (ATR) attachment with a diamond crystal was used. All of the cement specimens were 
20 coated with a thin film of Au-Pd using an ion sputter coater (E-101, Hitachi Co., Tokyo, Japan) 
21 prior to SEM observation. To determine the chemical structure of the quaternary ammonium 
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1 component leached from the cements, a cylindrical specimen 6 mm in diameter and 12 mm in 
2 height containing 40 % TBAEMA was soaked in 3 mL of ultrapure water for 1 d. The solution 
3 was analyzed by mass spectrometry in positive ion mode (JMS-SX102A, JEOL Ltd., Tokyo, 
4 Japan).
5
6 2.7.  Antibacterial activity test
7 Cylindrical cement samples, 6 mm in diameter and 12 mm in height, modified with different 
8 amounts of TBAEMA were soaked in 5 mL of Luria-Bertani (LB) Lennox culture medium (10 g 
9 of tryptone, 5 g of yeast extract and 5 g of NaCl for 1 L)26 and sterilized using an autoclave (BS-
10 245, TOMY SEIKO Co., Ltd., Tokyo Japan) at 120°C for 20 min. After cooling to room 
11 temperature, the samples were transferred to test tubes and shaken in a constant temperature 
12 incubator (MM-10, TAITEC Co., Saitama, Japan) for a certain period (1 or 10 d) at 37°C and 120 
13 rpm. After removing the cements, two kinds of Gram-positive bacteria—Staphylococcus aureus 
14 (S. aureus) strain 209P and Bacillus subtilis (B. subtilis) strain ATCC 6633—and the Gram-
15 negative Escherichia coli (E. coli) strain NIHJ, were individually inoculated to be 0.05 of OD620 
16 as the initial cell turbidity of each bacterial strain, corresponding to 1–5 × 107 CFU/mL. The 
17 mixtures were then incubated at 37°C and 120 rpm for 4 or 8 h.27–29 The turbidity and transmittance 
18 in the tubes were measured using a spectrometer (miniphoto518R, TAITEC Co., Saitama, Japan) 
19 at 620 nm. At least three samples were tested for each composition.
20
21 3. Results 
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1 Figure 2 shows the setting time of cements modified with different amounts of TBAEMA. 
2 The setting time increased with increasing TBAEMA content, and satisfied the requirement of ISO 
3 5833 for all TBAEMA contents of 10% or less. The cement did not set at ambient temperature 
4 when the TBAEMA content exceeded 40%. If the setting time is too short, handling by a medical 
5 doctor becomes quite difficult. In the opposite case, there is a risk of mixing of the cement paste 
6 with surrounding body fluid including blood before the setting, leading to degradation of the 
7 mechanical strength. Therefore, moderate setting rate regulated by ISO is important. Maximum 
8 temperature of the cement paste after the mixing is shown in Fig. 3. The temperature decreased 
9 with increase in TBAEMA content. It did not exceed the maximum temperature of conventional 
10 bone cements.
11 Figure 4 shows the compressive strength of cements modified with different amounts of 
12 TBAEMA. The compressive strength decreased with increasing TBAEMA content, and satisfied 
13 the requirement of ISO 5833 for TBAEMA contents of 5% or less. 
14 Figure 5 shows FT-IR ATR spectra of the cements with TBAEMA content of 0 and 10%. In 
15 addition to a lot of bands derived from MMA, MPS and calcium acetate, C-N band derived from 
16 TBAEMA was observed around 1400 cm-1 at TBAEMA content of 10%.30-34
17 Figure 6 shows SEM images of the surfaces of cements modified with different amounts of 
18 TBAEMA, as well as Cobalt G-HV cement, before and after soaked in SBF for 7 d. A lot of 
19 spherical PMMA particles were observed before soaking. On the other hand, assemblies of fine 
20 particles covered the surfaces of all of the modified cements. Such particles were also partially 
21 observed on the Cobalt G-HV cement. The particle morphology was similar to that of apatite 
22 formed in SBF.35 The TF-XRD patterns of the same samples are shown in Fig. 7. Broad peaks 
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1 assigned to hydroxyapatite (JCPDS#09-0432) with low crystallinity were detected at 
2 approximately 26  and 32  for all of the modified cements, but not for Cobalt G-HV cement. Peaks ° °
3 assigned to monoclinic ZrO2 (JCPDS#83-0944), added as an X-ray opacifier, were detected for 
4 the Cobalt G-HV cement. We found that the addition of TBAEMA had little influence on apatite 
5 formation.
6 Figure 8 shows the turbidity of the LB culture medium after soaking the TBAEMA modified 
7 cements for 1 or 10 d and subsequently incubating the extract with various bacteria for 4 or 8 h. A 
8 decrease in the turbidity corresponded to a decrease in the concentration of bacteria. The turbidity 
9 tended to decrease as the amount of TBAEMA in the cement increased, regardless of the extraction 
10 time or culture time. The turbidity increased slightly when the bacterial culture time was increased 
11 from 4 h to 8 h. When the cements containing 40% TBAEMA were extracted for 10 d, B. subtilis 
12 was completely killed. However, E. coli was more susceptible as it was completely killed at 30%. 
13 The antibacterial properties varied in the order of susceptibility: E. coli>B. subtilis>S. aureus for 
14 samples extracted for 10 d.
15 Figure 9 shows the mass spectrum of ultrapure water after soaking the 40% TBAEMA 
16 modified cement for 1 d. Peaks assigned to protonated C6H15NO and C10H19NO2 were detected at 
17 m/z 118.12 and 186.15, respectively. C6H15NO and C10H19NO2 correspond to an aminoalcohol 
18 formed by hydrolysis of TBAEMA and the TBAEMA monomer, respectively.
19
20 4. Discussion
21 We found that PMMA cement modified with MPS and TBAEMA showed self-hardening 
22 properties at certain compositions (Figs. 2 and 5). However, the compressive strength tended to 
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1 decrease as TBAEMA content increased (Fig. 4). According to the mass spectrum in Fig. 9, the 
2 amount of TBAEMA (m/z=186.15) eluted was much larger than that of MMA (m/z=100.11). Erol 
3 et al.36 reported that the monomer reactivity ratio of (2 ‐ oxo ‐ 2 ‐ tert ‐ butylamino)ethylene 
4 methacrylate containing amino groups is lower than that of styrene. Paleari et al.37 synthesized a 
5 copolymer of TBAEMA and MMA for use as a denture base and found that the decrease in the 
6 degree of polymerization and associated residual monomer serve as a plasticizer, thereby reducing 
7 the strength of the copolymer. Therefore, the residual monomer may result in reduced mechanical 
8 strength. This is supported by the results in Fig. 3 showing reduction of polymerization 
9 temperature at high TBAEMA content. It has been reported that the mechanical strength of PMMA 
10 bone cement is improved by the incorporation of cross-linking.38 Additionally, since the 
11 polymerization initiators and accelerators used are optimized for MMA, further studies are needed 
12 regarding the improvement of radical polymerization of TBAEMA in future work. 
13 The apatite-forming properties of the cements in SBF were almost the same regardless of 
14 the amount of TBAEMA added (Figs. 6 and 7). It is known that the ability of amino groups to 
15 form apatite is not as great as those of carboxyl or phosphate groups.39 Nevertheless, the addition 
16 of TBAEMA did not reduce apatite formation. This is probably the result of sufficient Ca2+ being 
17 released from the cement. Interestingly, commercial Cobalt G-HV cement also formed a small 
18 amount of apatite (Fig. 6). Because PMMA cement itself does not show apatite formation,7 it is 
19 thought that the added gentamicin contributes to apatite formation in the case of Cobalt G-HV. 
20 Although the detailed mechanism is not currently clear, gentamicin has the ability to form 
21 complexes with various cations40 and anions;41 therefore, it is thought that the complex formed in 
22 SBF induced apatite formation. Also, there is possibility of synergy effect of zirconia added as 
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1 opacifier, since a kind of hydrated zirconia has apatite-forming ability.42 The above observation 
2 may lead to the design of novel gentamicin-based materials with both bioactivity and antibacterial 
3 activity.
4 We found that the prepared cement exhibited antibacterial activity even in the form of an 
5 extract (Fig. 8). The cement with TBAEMA content of 5% had the desired setting behavior and 
6 mechanical properties. Its antibacterial activity against E. coli and S. aureus was lower than that 
7 of the previously reported cement with quaternary ammonium dendrimer of 5%, that exhibited 
8 comparable antibacterial activity to commercial antibacterial bone cement.24 This difference is 
9 attributed to differences in the culture methods. In the previous study, bacteria were cultivated with 
10 the powdered cement; however, in this study they were cultured with the extracts of the set cements. 
11 The condition of the present study would reproduce the actual clinical environment more 
12 accurately. It is therefore expected that the antibacterial activity of the present cement would be 
13 enhanced if the bacteria made direct contact with the cement. It was also found from Fig. 8 that 
14 even the cements without TBAEMA showed suppression of the bacteria growth to some extent. 
15 The addition of NaCl or CaCl2 into culture media is reported to be more effective for growth 
16 inhibition of L. pentosus and S. cerevisiae than KCl or MgCl2.43 It is therefore expected that the 
17 released Ca2+ contributes to the antibacterial activity of the incorporated quaternary ammonium. 
18 Gram-negative E. coli showed greater susceptibility to the cement extracts than the Gram-
19 positive bacteria S. aureus and B. subtilis. This difference can be explained by the properties of 
20 the outer membranes of the bacteria.44 The bactericidal efficacy of poly(TBAEMA) depends on a 
21 high surface density of positive charge. Gram-negative bacteria are more negatively charged on 
22 the surface than Gram-positive bacteria and therefore interact with poly(TBAEMA)-based 
23 cements more strongly.
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1 Of the tested Gram-positive bacteria, B. subtilis was more susceptible to the cement extracts 
2 than S. aureus. Although the tendency is not consistent, previous studies using polymers with 
3 quaternary ammonium groups have shown differences in sensitivity for different bacteria.34,36 In 
4 this study—owing to the fact that the eluted monomers and hydrolysis products contribute to the 
5 antibacterial activity—the difference may be caused by the morphology of the bacteria. Namely, 
6 S. aureus has spherical morphology,45 whereas B. subtilis is more wrinkled and uneven46. 
7 Additionally, the former easily form a cluster. Therefore, the specific surface area and number of 
8 available adsorption sites would be larger for B. subtilis than for S. aureus. It has also been reported 
9 that antibacterial activity is governed by molecular weight.34 Increasing the molecular weight of 
10 the cement is important for enhancing the mechanical properties. Therefore, the relationship 
11 between the degree of polymerization and the antibacterial activity should be further investigated. 
12
13 5. Conclusion
14 PMMA cement exhibiting both bioactivity and antibacterial activity was obtained by 
15 chemical modification with quaternary ammonium, alkoxysilane, and water-soluble calcium salt. 
16 The cement showed greater antibacterial activity against E. Coli, a Gram-negative bacterium, as 
17 compared to two Gram-positive bacteria, S. aureus and S. subtilis. The findings demonstrate the 
18 potential to develop a novel bioactive bone cement with sustained antibacterial activity and high 
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2   
3 Table 1  Composition of the powder and liquid phases of the modified cements
4
Powder (per 1 g) / mg Liquid (per 0.5 g) / mg
PMMA BPO Calcium 
acetate MMA TBAEMA MPS NDT
777 29 194 x (486-x) 9.7 3.9
5
6
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2 Figure 1  Assumed chemical structure of the cement prepared in this study.
3 Figure 2  Setting time of cements modified with different amounts of 2-(tert-butylamino)ethyl 
4 methacrylate (TBAEMA).
5 Figure 3  Maximum temperature of the cement paste after the mixing.
6 Figure 4  Compressive strength of cements modified with different amounts of TBAEMA.
7 Figure 5  FT-IR ATR spectra of the cements with TBAEMA content of 0 and 10%.
8 Figure 6  SEM images of the surfaces of cements modified with different amounts of TBAEMA 
9 and Cobalt G-HV cement before and after soaked in SBF for 7 d.
10 Figure 7  TF-XRD patterns of the surfaces of cements modified with different amounts of 
11 TBAEMA and Cobalt G-HV cement. All samples were soaked in SBF for 7 d.
12 Figure 8  Turbidity of LB culture medium after soaking the TBAEMA modified cements for 1 or 
13 10 d and subsequently incubating the extracts with various bacteria for 4 or 8 h. * and ns denote 
14 p<0.05 and no significance, respectively.
15 Figure 9 Mass spectrum of ultrapure water after soaking the cement with 40% TBAEMA content 
16 for 1 d.
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